Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings.
Dittmann RW, Wehmeier PM, Schacht A, Lehmann M, Lehmkuhl G. Dittmann RW, et al. Atten Defic Hyperact Disord. 2009 Dec;1(2):187-200. doi: 10.1007/s12402-009-0011-5. Epub 2009 Sep 23. Atten Defic Hyperact Disord. 2009. PMID: 20234829 Free PMC article. Clinical Trial.
European guidelines on managing adverse effects of medication for ADHD.
Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann RW, Döpfner M, Hamilton R, Hollis C, Holtmann M, Hulpke-Wette M, Lecendreux M, Rosenthal E, Rothenberger A, Santosh P, Sergeant J, Simonoff E, Sonuga-Barke E, Wong IC, Zuddas A, Steinhausen HC, Taylor E; European Guidelines Group. Graham J, et al. Among authors: dittmann rw. Eur Child Adolesc Psychiatry. 2011 Jan;20(1):17-37. doi: 10.1007/s00787-010-0140-6. Epub 2010 Nov 3. Eur Child Adolesc Psychiatry. 2011. PMID: 21042924 Free PMC article.
Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM. Dittmann RW, et al. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97-110. doi: 10.1089/cap.2009.0111. Epub 2011 Apr 13. J Child Adolesc Psychopharmacol. 2011. PMID: 21488751 Clinical Trial.
Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device.
Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T. Wehmeier PM, et al. Among authors: dittmann rw. J Child Adolesc Psychopharmacol. 2011 Oct;21(5):433-44. doi: 10.1089/cap.2010.0142. J Child Adolesc Psychopharmacol. 2011. PMID: 22040189 Clinical Trial.
130 results